June 23, 2021

$CMMB Chemomab Therapeutics Rises 4% On AGC Biologics Expanded Agreement

CMMB stock rose in early trading on June 23, 2021, after the company announced an expanded agreement with AGC Biologics to produce CM-101, a Phase II investigational drug targeting Primary

Biotechnology

June 23, 2021

$ENTX Entera Bio Announces Excellent Topline Phase 2 BMD Data

ENTX stock rose more than 21% in pre-market trading on June 23, 2021, after the company reported excellent phase 2 data. Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development

Biotechnology

June 22, 2021

$SRNE Sorrento Therapeutics Candle Over Candle On R&D Agreement with U.S. Navy

SRNE stock formed a candle over candle reversal on June 22, 2021, after an agreement With the U.S. Naval Medical Research Unit was announced. Broad multi-year agreement between Sorrento Therapeutics and

Biotechnology

June 22, 2021

$ATOS Atossa Therapeutics Bullish Option Flow Detected

Bullish option flow was detected in ATOS stock on June 22, 2021. On June 11, 2021, Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical-stage biopharmaceutical company seeking to discover and develop innovative

Biotechnology

June 22, 2021

$BPTH Bio Path Stock Higher On Patent

BPTH stock rose more than 7% in early trading on June 22, 2021, after the company was granted a patent. Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize®

Biotechnology

June 15, 2021

$ATRA Atara Biotherapeutics Large Insider Buy Detected

A large insider buy was detected in ATRA stock on June 15, 2021. In a regulatory filing, Atara Biotherapeutics disclosed that its Chief Commercial Officer Kristin Yarema bought 34.3K shares of

Biotechnology

May 24, 2021

$SCPS Scopus BioPharma Pump and Dump On Chart

SCPS stock formed a classic pump and dump pattern on its intraday chart today after a press release. Here is the intraday chart of SCPS stock: The stock soared 110% on the

Biotechnology

April 28, 2021

$ADMA ADMA Biologics Stock Up On FDA Approval for Increased IVIG Production Scale

ADMA stock rose in early trading on April 28, 2021, after the company announced that it has received FDA approval for increased IVIG production. ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical

Biotechnology

March 9, 2021

$ANPC AnPac Bio-Medical Science Evaluates New Cancer Detection Sensor

ANPC stock rose in pre-market trading on new cancer detection sensor. AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and

Biotechnology

February 16, 2021

$SESN Sesen Bio Stock Soars In Pre-market On FDA Priority Review

SESN stock rose more than 9% in pre-market trading on February 16, 2021, after the company announced that it has received priority review from the FDA for its Vicineum. Sesen Bio

« Older Articles